Joseph Truitt's Insider Trades & SAST Disclosures

Joseph Truitt's most recent trade in Larimar Therapeutics Inc was a trade of 19,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 29, 2024.

Share

Note

This is a custom search result for pattern Joseph Truitt.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Show

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Larimar Therapeutics Inc Board Meeting 52 week low	Joseph Truitt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 May 2024	19,000	19,000	-		-	Stock Option (Right to Buy)
Larimar Therapeutics Inc Board Meeting 52 week low	Joseph Truitt	Director	Purchase of securities on an exchange or from another person at price $ 3.73 per share.	17 May 2023	2,750	2,750	-	3.7	10,258	Common Stock
Larimar Therapeutics Inc Board Meeting 52 week low	Joseph Truitt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 May 2023	8,300	8,300	-		-	Stock Option (Right to Buy)
Larimar Therapeutics Inc Board Meeting 52 week low	Joseph Truitt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2022	8,300	8,300	-		-	Stock Option (Right to Buy)
Larimar Therapeutics Inc Board Meeting 52 week low	Joseph Truitt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 May 2021	8,300	8,300	-		-	Stock Option (right to buy)
Larimar Therapeutics Inc Board Meeting 52 week low	Joseph Truitt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Sep 2020	16,600	16,600	-		-	Stock Option (right to buy)

Showing 1 to 6 of 6 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades